Ironwood Pharmaceuticals, Inc. ( IRWD) - Key Metrics
IRWD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.29 | -$0.01 | $0.66 | $0.66 |
| 2025Q3 | $0.75 | $0.25 | $0.29 | $0.29 |
| 2025Q2 | $0.53 | $0.15 | -$0.09 | -$0.09 |
| 2025Q1 | $0.26 | -$0.23 | $0.12 | $0.12 |
IRWD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -60.05 |
| 2025Q3 | ? | 1.33 |
| 2025Q2 | ? | 1.23 |
| 2025Q1 | ? | -1.58 |
IRWD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.89% | ? |
| 2025Q4 | 13.64% | ? |
| 2025Q3 | 22.39% | ? |
| 2025Q2 | -12.99% | ? |
| 2025Q1 | 8.42% | ? |
IRWD
Price: $3.40
52 week price:
Earnings Per Share: 0.62 USD
P/E Ratio: 5.94
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 405820
Ebitda: 26.2 millionMarket Capitalization: 605.8 million